An instance of prostate cancer that is caused by an inherited genomic modification in an individual. Familial prostate cancer (FPC) is a malignant tumor of the prostate with an early onset. FPC is eit...
Comprehensive, easy-to-understand information about this condition
How we create this content →Research studies investigating treatments and therapies for this condition.
Active Trials
Total Trials
Data from ClinicalTrials.gov Feb 5, 2026
Research studies investigating treatments and therapies for this condition.
Active Trials
Total Trials
Data from ClinicalTrials.gov Feb 5, 2026
Helpful links for rare disease information and support
Questions that may be helpful when speaking with your healthcare team
Research studies investigating treatments and therapies for this condition.
Active Trials
Total Trials
Data from ClinicalTrials.gov Feb 5, 2026
Online Mendelian Inheritance in Man
European rare disease database
AI-Generated Content: This summary was generated using AI. Always consult with qualified healthcare providers for medical guidance.
Kisho delivers this disease record via API, including phenotypes (HPO), genes, orphan drug designations, screening status, and PAG mapping, with version history and governance.
AI-curated news mentioning prostate cancer, hereditary
Updated Feb 20, 2026
A new study published in PubMed examines cancer-specific mortality rates in rare histological subtypes of prostate cancer, comparing outcomes between radical prostatectomy and radiation therapy. This research could inform treatment decisions for patients with these rare subtypes.
A recent case report highlights the genetic diagnosis of macrotia in patients with PIK3CA-Related Overgrowth Spectrum (PROS) and discusses the long-term outcomes of otoplasty. This study contributes to the understanding of genetic factors in PROS and the effectiveness of surgical interventions.
A systematic review analyzed data from 32 phase III clinical trials on hypofractionated radiotherapy for prostate cancer, highlighting the lack of significant toxicity compared to external beam radiotherapy. The findings suggest that while brachytherapy may not be suitable for all patients, it remains a valuable treatment option.